Press Releases
Search
August 8, 2023
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2023 Financial Results
June 9, 2023
Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock
June 7, 2023
Cogent Biosciences Announces Participation in the Jefferies Healthcare Conference
June 6, 2023
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock
June 6, 2023
Cogent Biosciences Announces Proposed Public Offering of Common Stock
June 3, 2023
Cogent Biosciences Announces Positive Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST)
May 23, 2023
Cogent Biosciences to Host Investor Webcast to Discuss Lead-In Data Being Presented at ASCO from the Ongoing Phase 3 PEAK Trial in Patients with Gastrointestinal Stromal Tumors (GIST)
May 9, 2023
Cogent Biosciences Reports Recent Business Highlights and First Quarter 2023 Financial Results
April 17, 2023
Cogent Biosciences Presents Preclinical Data at AACR Annual Meeting Highlighting Precision Therapy Pipeline and Announces Initiation of Part 2 of the Registration-Enabling APEX Trial with Bezuclastinib in Advanced Systemic Mastocytosis
April 12, 2023
Cogent Biosciences Announces Participation at Upcoming Investor Conferences
Displaying 1 - 10 of 14
The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Unum disavows any obligation to update the information contained in such press releases after the date of their issuance.